Screener
Lexicon Pharmaceuticals LXRX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Assets | As of June 30, 2026 / (unaudited) | As of December 31, 2025 |
|---|---|---|
| Goodwill | 44,543 | 44,543 |
| Operating lease right-of-use-assets | 6,921 | 7,318 |
| Restricted cash | — | 29,000 |
| Other assets | 368 | 368 |
| Total assets | $250,060 | $184,987 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,343 | $3,083 |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's deferred tax assets and other non-current assets?
- Lexicon Pharmaceuticals (LXRX) reported deferred tax assets and other non-current assets of $368K in Q2 2026.
- How has Lexicon Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?
- Lexicon Pharmaceuticals's deferred tax assets and other non-current assets decreased by 0.0% year-over-year, from $368K to $368K.
- What is the long-term trend for Lexicon Pharmaceuticals's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's deferred tax assets and other non-current assets has grown at a -21.5% compound annual growth rate (CAGR), from $1.23M to $368K.
- What does deferred tax assets and other non-current assets mean?
- Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.
Ask your AI about Lexicon Pharmaceuticals's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude